Search by Algolia
Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
I-ON Digital Corp.I-ON Digital Corp. Reports Zero Revenue and Increased Losses in Q1 2025
ASTROTECH CorpAstrotech Corporation Reports Q3 Revenue Surge to $534,000 Amid Mixed Nine-Month Results
Neonode Inc.Neonode Reports $1.7 Million Net Loss in Q1 2025, Revenue Declines 37%
Dermata Therapeutics, Inc.Dermata Therapeutics Reports Q1 2025 Financial Results with Reduced Net Loss
Inhibitor Therapeutics, Inc.Inhibitor Therapeutics Reports Q1 2025 Financial Results with Net Loss of $632,846
Sow Good Inc.Sow Good Inc. Reports 78% Revenue Decline and $2.6 Million Net Loss in Q1 2025
IO Biotech, Inc.IO Biotech Reports $22.4 Million Net Loss in Q1 2025, Increases R&D Spending
Urgent.ly Inc.Urgent.ly Reports 22% Revenue Decline in Q1 2025 Amid Customer Losses
SusGlobal Energy Corp.SusGlobal Energy Corp. Reports 87% Revenue Decline and Increased Losses for Fiscal Year 2024
Zoned Properties, Inc.Zoned Properties Reports 16.4% Revenue Growth to $974,552 in Q1 2025
Theriva Biologics, Inc.Theriva Biologics Reports $4.3 Million Net Loss, Focuses on Oncology Pipeline
Leatt CorpLeatt Corporation Reports 45% Revenue Growth to $15.37 Million in Quarterly Results
Aprea Therapeutics, Inc.Aprea Therapeutics Reports $3.9 Million Net Loss in Q1 2025, Seeks Additional Funding
DeFi Development Corp.DeFi Development Corp. Reports $287K Revenue, 30% Decline, and Strategic Shift to Subscription Services
CREATIVE REALITIES, INC.Creative Realities Reports 21% Revenue Decline and Operating Loss in Q1 2025
Longduoduo Co LtdLongduoduo Company Limited Reports Significant Revenue Decline and Net Loss for Q3 and Nine Months Ended March 31, 2025
Indaptus Therapeutics, Inc.Indaptus Therapeutics Reports $4.5 Million Net Loss in Q1 2025, Seeks Additional Capital
Maitong Sunshine Cultural Development Co., LtdMaitong Sunshine Reports 59% Revenue Decline and Net Loss for Six Months Ending March 31, 2025
Inozyme Pharma, Inc.Inozyme Pharma Reports $28M Net Loss in Q1 2025, Announces Workforce Reduction
Marathon Bancorp, Inc. /MD/Marathon Bancorp Reports Net Income of $148,403 for Q1 2025, Significant Turnaround from Previous Year
Verve Therapeutics, Inc.Verve Therapeutics Reports $32.98M Collaboration Revenue and $31.03M Net Loss for Q1 2025
Advanced Flower Capital Inc.Advanced Flower Capital Inc. Reports $4.1 Million Net Income in Q1 2025
Scholar Rock Holding CorpScholar Rock Reports $74.7 Million Net Loss in Q1 2025, Increases Focus on Apitegromab
Centessa Pharmaceuticals plcCentessa Pharmaceuticals Reports $15M Revenue and $26.1M Net Loss in Q1 2025
Climb Bio, Inc.Climb Bio Reports $20.8 Million Net Loss and Increased R&D Expenses in Latest 10-Q Filing